Your session is about to expire
← Back to Search
Patient Education
Prescription Aid + Pain Management App for Postoperative Pain (EQUIPPED Trial)
N/A
Waitlist Available
Led By Karsten Bartels, MD, PhD, MBA
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
EQUIPPED Trial Summary
This trial seeks to reduce the amount of opioids prescribed and taken by patients following surgery through the use of a provider-facing decision support tool and a patient-facing smartphone app.
Who is the study for?
This trial is for adults aged 19-89 who've had inpatient surgery requiring an overnight stay and are going home after. They must be able to read English, not pregnant, not using long-term opioids before surgery, and have a smartphone.Check my eligibility
What is being tested?
The study tests a tool that helps doctors prescribe fewer opioids and a smartphone app that lets patients manage their pain post-surgery. The goal is to reduce opioid use while controlling pain effectively.See study design
What are the potential side effects?
Since this trial focuses on reducing opioid prescriptions rather than administering new drugs, side effects may include discomfort or inadequate pain control if non-opioid strategies are less effective.
EQUIPPED Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Opioids
Secondary outcome measures
Opioid disposal
Opioid prescription on day of discharge
Opioids prescribed from "day of discharge + 1" until 28 days after discharge
+2 moreEQUIPPED Trial Design
4Treatment groups
Active Control
Group I: UControlPain app AND provider facing toolActive Control2 Interventions
UControlPain app with education components and provider-facing prescription intervention.
Group II: Provider facing tool onlyActive Control1 Intervention
UControlPain App with only data collection function. Provider-facing prescription intervention.
Group III: ControlActive Control1 Intervention
UControlPain App with only data collection function. No provider-facing prescription intervention.
Group IV: UControlPain educational app onlyActive Control1 Intervention
UControlPain app with education components. No provider-facing prescription intervention.
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
536 Previous Clinical Trials
1,143,211 Total Patients Enrolled
Karsten Bartels, MD, PhD, MBAPrincipal InvestigatorUniversity of Nebraska
1 Previous Clinical Trials
520 Total Patients Enrolled
Karsten Bartels, MD PhD MBAPrincipal InvestigatorUniversity of Nebraska
1 Previous Clinical Trials
520 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are admitted to hospital for surgery requiring at least over-night hospitalization.You are between 20 and 88 years old.You were recently discharged to a facility for continued care after leaving the hospital.You cannot take medications like opioids, acetaminophen, or NSAIDs for medical reasons.You must be between 19 and 89 years old to participate.You were in the hospital again within 30 days of your last stay.You have been taking opioid medication almost every day for more than 3 months before the surgery.
Research Study Groups:
This trial has the following groups:- Group 1: UControlPain app AND provider facing tool
- Group 2: Provider facing tool only
- Group 3: Control
- Group 4: UControlPain educational app only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Post-Surgical Complication Patient Testimony for trial: Trial Name: NCT05221866 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment seeking octogenarian participants?
"This trial has an age restriction of 19 to 89 years old, as indicated in its enlistment criteria."
Answered by AI
What is the capacity of this medical trial?
"Yes, the information on clinicaltrials.gov confirms that this experiment is actively seeking participants. Initially posted on March 14th 2022 and most recently updated May 27th 2022, 600 patients are needed to be enrolled at one medical centre."
Answered by AI
Is this experiment actively seeking participants?
"According to the most recent info posted on clinicaltrials.gov, investigators are actively recruiting for this medical trial which had its inception on March 14th 2022 and was last revised on May 27th 2022."
Answered by AI
Is my involvement in this research project permissible?
"This clinical trial needs 600 participants aged between 19 and 89 who have opioid addiction. Additionally, individuals must own a smartphone (iOS or Android) and are expecting to undergo inpatient surgery with an overnight hospital stay followed by discharge home."
Answered by AI
Who else is applying?
What state do they live in?
Nebraska
What site did they apply to?
University of Nebraska Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Why did patients apply to this trial?
Opioids are the only thing that ease my constant chronic pain and I am unable to work due to my pain and injuries, so financial compensation is also definitely a contributing factor.
PatientReceived no prior treatments
What questions have other patients asked about this trial?
What are the possible risks and side effects? And what kind of compensation can I expect to receive?
PatientReceived 2+ prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger